All the news Showing 9 of 29 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources How often does COVID-19 cause liver disorders? Keith Alcorn / 21 July 2020 Increases in liver enzymes are common in people with COVID-19 and occur more frequently in people with severe COVID-19, a meta-analysis of studies published in Hepatology International shows. Most liver enzyme elevations were ... Hepatitis C drugs may offer an inexpensive treatment option for COVID-19 Liz Highleyman / 20 July 2020 Sofosbuvir and daclatasvir, two antiviral drugs used to treat hepatitis C, were associated with faster recovery, shorter hospitalisation and improve survival among people with moderate or severe COVID-19, researchers reported this month at the ... Cirrhosis raises the risk of liver injury in COVID-19 patients Keith Alcorn / 13 July 2020 People with cirrhosis, especially those with diabetes or obesity, are more likely to suffer significant liver injury after contracting SARS-CoV-2 than others with chronic liver disease, Asian liver specialists report in a ... Non-alcoholic fatty liver disease does not raise the risk of COVID-19, gene study shows Keith Alcorn / 26 May 2020 People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ... COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death Keith Alcorn / 22 May 2020 People with chronic liver disease admitted to hospital with COVID-19 are dying at a much higher rate than the rest of the population, figures collated by liver specialists in Europe, Asia and ... Liver transplants and COVID-19 Keith Alcorn / 28 April 2020 Liver specialists in New York report a high frequency of severe COVID-19 cases in organ transplant recipients who became infected with SARS-CoV-2, while Italian specialists report that 15 of 17 patients who underwent ... Fatty liver disease may increase risk of severe COVID-19 disease Keith Alcorn / 27 April 2020 A preliminary analysis of people admitted to hospital in China with COVID-19 symptoms shows that people with non-alcoholic fatty liver disease (NAFLD) were six times more likely to progress to severe COVID-19 ... Coronavirus (COVID-19, SARS-CoV-2) and viral hepatitis: sources of information Keith Alcorn / 26 March 2020 COVID-19 is a new illness that can affect your lungs and airways. It's caused by a virus called coronavirus. The most common symptoms of coronavirus are a fever (high temperature) and/or dry cough, shortness of ... Liver specialists offer guidance on COVID-19 risks in liver patients Keith Alcorn / 25 March 2020 The American Association for the Study of Liver Diseases (AASLD) has issued preliminary guidance for liver specialists on managing COVID-19 in patients with liver disease, based on data published up to late March. COVID-19 ... ← Prev123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive